Four (four of 13) persons with an inhibitor had mild, two (two of 13) had moderate, and seven (seven of 13) had severe hemophilia A. Most persons with an inhibitor (10/13) had over 150 cumulative exposure days to FVIII. This evidence concerns the gene F8 and hemophilia A.